State of Wyoming Invests $443,000 in Aveanna Healthcare Holdings Inc. $AVAH

State of Wyoming bought a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the second quarter, Holdings Channel reports. The firm bought 51,723 shares of the company’s stock, valued at approximately $443,000.

Several other large investors have also added to or reduced their stakes in AVAH. Vanguard Group Inc. boosted its stake in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares during the last quarter. Millennium Management LLC raised its stake in shares of Aveanna Healthcare by 1,007.1% in the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after purchasing an additional 1,014,030 shares during the last quarter. Nuveen LLC raised its stake in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Aveanna Healthcare by 451.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 959,488 shares of the company’s stock valued at $8,511,000 after purchasing an additional 785,452 shares in the last quarter. Finally, Zimmer Partners LP bought a new position in shares of Aveanna Healthcare in the fourth quarter valued at approximately $6,189,000. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on AVAH. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price target for the company in a report on Wednesday, June 3rd. Raymond James Financial raised their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research note on Friday. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Truist Financial upped their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Finally, Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $11.78.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 7,000,000 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the completion of the transaction, the insider owned 252,899 shares in the company, valued at $1,578,089.76. This trade represents a 96.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the completion of the sale, the insider directly owned 252,899 shares in the company, valued at approximately $1,578,089.76. This trade represents a 96.51% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 31,305,664 shares of company stock worth $215,555,910 over the last ninety days. Company insiders own 5.30% of the company’s stock.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH opened at $12.69 on Tuesday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a fifty day simple moving average of $9.10 and a two-hundred day simple moving average of $7.78. Aveanna Healthcare Holdings Inc. has a 1-year low of $5.93 and a 1-year high of $12.70. The firm has a market cap of $2.77 billion, a price-to-earnings ratio of 10.32, a price-to-earnings-growth ratio of 1.22 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.